15 results about "Sleep problem" patented technology

The invention provides a mattress type sleep monitoring data real-time processing method based on edge calculation, relates to the technical field of medical health data processing, and aims to perform macroscopic state layer calculation, pathological event layer calculation and stability layer calculation at the same time in a layering manner based on a constructed dynamic sensing matrix, generate a structured sleep health report, and realize real-time sleep monitoring through one-time sleep monitoring. The comprehensive information about the sleep macrostructure, the respiratory pathology event burden and the sleep stability can be synchronously output; through a sleep health assessment report, total sleep duration and sleep efficiency calculated by the macroscopic state layer, apnea and type and severity calculated by the pathological event layer, and a sleep micro-awakening state and sleep fragmentation degree calculated by the stability layer can be clearly known, and a multi-dimensional and integrated comprehensive assessment result with high medical value is realized. The information amount of the sleep health portrait is enriched, and a comprehensive and reliable data support is provided for accurately positioning the root of the sleep problem and formulating a personalized intervention or treatment scheme.

Provided are a multilayer fabric and a covering article capable of solving sleep problems in summer.　A comforter 1 in which a multilayer fabric covering a target portion is used, the target portion being at least a part of a person, such as a portion below the neck, includes: an inner knit fabric layer 11 coming into contact with the target portion; and a temperature-regulating batting layer 12 disposed on a side opposite to the target portion with respect to the inner knit fabric layer 11, and absorbing moisture from the target portion. The temperature-regulating batting layer 12 has: a batting body 121; and a moisture absorbing portion 122 provided on at least one surface of the batting body 121.

This invention discloses a sleep-aiding microneedle patch and its preparation method, belonging to the field of transdermal drug delivery technology. The preparation steps are as follows: Gastrodin and γ-aminobutyric acid are dissolved in deionized water, heated and stirred, then sodium hyaluronate is added, and the mixture is cooled and defoamed to obtain a needle tip layer solution; ethanol, dimethyl sulfoxide, and xanthan gum are mixed to obtain a base layer solution; after modifying a PDMS mold with PEG aqueous solution, the needle tip layer solution and the base layer solution are added sequentially, and the patch is demolded to obtain the final product. In this invention, the two components synergistically promote sleep, the microneedles have high transdermal absorption efficiency, can improve sleep problems without dependence or significant side effects; the optimized process solves the problems of difficult demolding and component residue; the substrate has good biocompatibility, no skin irritation, is convenient and painless to use, and is applicable to a wide range of scenarios.

The invention discloses a biofeedback-driven multi-mode sleep-aiding earphone control system, which belongs to the technical field of biomedical engineering and artificial intelligence, and is characterized in that an electroencephalogram signal, a heart rate variability signal, a respiratory rate signal and a body temperature signal of a user are collected in real time through a sensor array arranged in an earphone; the sleep preparation stage and physiological tension of the user are evaluated, the audio content and parameters are adaptively adjusted according to the evaluation result, the system innovatively integrates the respiration guiding function, the user respiratory frequency is induced to be synchronized through the audio rhythm, the parasympathetic nervous system is activated, and the personalized optimization engine based on reinforcement learning continuously learns historical data of the user. A sleep aiding scheme for thousands of people is achieved, the biological feedback closed-loop control module monitors the intervention effect in real time and dynamically adjusts the strategy, clinical tests show that the system can shorten the sleep latency period by 52% and improve the sleep quality score by 31%, and an intelligent solution is provided for improving the sleep problem.

Provided are compounds, methods, and pharmaceutical compositions for reducing the amount or activity of SCN2A RNA in a cell or subject, and in certain instances reducing the amount of SCN2A protein in a cell or subject. Such compounds, methods, and pharmaceutical compositions are useful to ameliorate at least one symptom or hallmark of a disease or disorder associated with a voltage-gated sodium channel protein, such as, for example, a Developmental and Epileptic Encephalopathy, an intellectual disability, or an autism spectrum disorder. Such symptoms and hallmarks include, but are not limited to seizures, hypotonia, sensory integration disorders, motor development delays and dysfunctions, intellectual and cognitive dysfunctions, movement and balance dysfunctions, visual dysfunctions, delayed language and speech, gastrointestinal disorders, neurodevelopmental delays, sleep problems, and sudden unexpected death in epilepsy.

The present application provides a method for detecting sleep problems and an electronic device. The electronic device can detect physiological data of a user, and determine sleep parameters of the user according to these physiological data. These sleep parameters can be used for determining an insomnia degree and an insomnia type of the user. The electronic device can also provide the insomnia degree, the insomnia type, and a sleep condition improvement suggestion for the insomnia type to the user, thereby assisting the user in solving the sleep problems. The method by which the electronic device determines the insomnia degree and / or the insomnia type can be dynamically adjusted according to the actual sleep condition of the user, so that the detection results of the sleep problems are more accurate and reliable, and the use experience of the user is better.

The invention provides a sleep quality detection method and electronic equipment, the electronic equipment can detect the sleep quality of a user through a sleep evaluation model, the sleep evaluation model can correspond to a user group, and / or the sleep evaluation model can be obtained according to historical sleep index parameters of the user. The user sleep quality determined through the method is higher in accuracy and closer to the actual sleep feeling of the user. According to the sleep quality detection method, the sleep problem possibly existing in the user can be more accurately detected and fed back to the user in time, corresponding improvement suggestions are provided, and the use experience of the user is good.

Provided are compounds, methods, and pharmaceutical compositions for reducing the amount or activity of UBE3A-ATS, the endogenous antisense transcript of ubiquitin protein ligase E3A (UBE3A) in a cell or subject, and in certain instances increasing the expression of paternal UBE3A and the amount of UBE3A protein in a cell or subject. Such compounds, methods, and pharmaceutical compositions are useful to ameliorate at least one symptom or hallmark of a neurogenetic disorder. Such symptoms and hallmarks include developmental delays, ataxia, speech impairment, sleep problems, seizures, and EEG abnormalities. Such neurogenetic disorders include Angelman Syndrome.

The invention provides a sleep problem detection method and electronic equipment, the electronic equipment can detect physiological data of a user and determine sleep parameters of the user according to the physiological data, and the sleep parameters can be used for determining the insomnia degree and the insomnia type of the user. The electronic device can also provide the insomnia degree, the insomnia type and the sleep condition improvement suggestions for the insomnia type to the user, thereby assisting the user in solving the sleep problem. The method for determining the insomnia degree and / or the insomnia type by the electronic equipment can be dynamically adjusted according to the actual sleep condition of the user, so that the detection result of the sleep problem is more accurate and reliable, and the use experience of the user is better.

Chronic pain patients complain about sleep disturbance with a high probability, while sleep loss increases pain in chronic pain patients. Sleep problems and pain promote a vicious spiral, suggesting a need for simultaneous treatment of both. The present invention provides a method to treat pain-related sleep disorders through distribution of a therapeutic amount of a KOR antagonist. The use of KOR antagonist could be a novel therapeutic agent for sleep disturbance in chronic pain patients. Additionally, KOR antagonists could be used to improve sleep in other conditions, such as depression or general anxiety disorder, where KOR signaling is induced.

The present application relates to the technical field of medicinal and edible products, and particularly discloses a medicinal and edible sleep-aiding beverage and a preparation method thereof. The active ingredients of the sleep-aiding beverage are prepared from the following raw materials in parts by weight: 10-60 parts of Chinese date seed, 5-30 parts of poria cocos, 5-30 parts of dried tangerine or orange peel, 5-20 parts of licorice, 2-30 parts of Gastrodia elata, 5-30 parts of Chinese date, 5-30 parts of lily, 5-30 parts of lotus seed, 5-30 parts of angelica, 1-30 parts of Cape jasmine fruit, 5-30 parts of dogwood fruit, 1-20 parts of cassia, 5-50 parts of lophatherum gracile, and 5-30 parts of raphanus sativus. The medicinal and edible sleep-aiding beverage can be used to improve sleep problems such as difficulty falling asleep, dreaminess, easy wake-up, light sleep, and post-sleep fatigue, and is suitable for long-term consumption by teenagers, adults and the elderly.

The invention discloses ginseng and spina date seed oral liquid for improving sleep and a preparation method of the ginseng and spina date seed oral liquid, and belongs to the technical field of functional food. The ginseng and spina date seed oral liquid comprises the following components in parts by weight: 60-70 parts of spina date seed and ginseng composite extracting solution and 30-40 parts of radix rehmanniae preparata and caulis polygoni multiflori composite extracting solution. The weight ratio of ginseng to spina date seeds in the spina date seed and ginseng compound extracting solution is 1: (3-4); the weight ratio of the prepared rehmannia root to the vine of multiflower knotweed in the prepared rehmannia root and vine of multiflower knotweed composite extracting solution is 1: (1-1.5). By reasonably adjusting the proportion of the medicinal materials, the synergistic effect of effective components in the ginseng and spina date seed oral liquid is improved, the nutritional and health-care effects are achieved, the influence of sleep problems on consumers is relieved, and the sleep quality of the consumers is improved.

This invention discloses a home-based sleep quality optimization aid for patients with chronic diseases, relating to the field of sleep assistance technology. It includes an adjustment controller and a wire. One end of the wire is fitted with an earplug, and the other end of the earplug is fitted with a rubber sleeve. An elastic strip is provided on the outer circumference of the earplug for conforming to the patient's concha. A detection component for detecting the patient's sleep state and a stimulation component for optimizing the patient's sleep quality are located on one side of the elastic strip. The stimulation component includes an outer sleeve fixedly connected to the elastic strip, an inner sleeve fixedly connected inside the outer sleeve, and a first electrode disposed inside the outer sleeve. This invention can effectively improve sleep problems such as difficulty falling asleep, frequent awakenings at night, and insufficient deep sleep duration in this population, breaking the vicious cycle of poor sleep quality and slow recovery, effectively optimizing the home-based sleep quality of patients with chronic diseases, and aiding in physical recovery.

This application provides a battery charging control method, electronic device, and vehicle. The method includes: acquiring the vehicle's battery voltage and a desired charging voltage; and, in response to determining that the battery voltage is less than a preset sleep voltage, executing an anti-sleep charging strategy. The anti-sleep charging strategy involves controlling the vehicle to charge at a target charging voltage, where the target charging voltage is determined based on the preset anti-sleep voltage, and the anti-sleep voltage is greater than the battery voltage. This application executes the anti-sleep charging strategy when the battery voltage is less than the preset sleep voltage to boost the battery voltage and avoid low-voltage sleep problems.

Devices and methods are provided for inhibiting mouth breathing and / or improving nasal breathing, e.g., for PAP users or users with other sleeping problems. In an exemplary embodiment, an adhesive device is provided that includes an elongate membrane comprising first and second ends and side edges extending between the first and second ends, a first surface comprising an adhesive layer. The adhesive layer may be a low tack adhesive that is adherent to skin, yet is also easily removable without leaving significant residue. Optionally, the device may include one or more valves to provide one-way flow across the membrane, one or more weakened regions in the membrane, and / or one or more tabs to facilitate removal of the membrane from over a user's mouth.